Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending December 5, 2008. The report details a specific share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 21, 2008.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Repurchased: 644,360 Ordinary shares.
- Repurchase Price: 1,190.79 pence per share.
- Treasury Shares Held: 474,194,158 shares (representing 9.13% of total voting rights).
- Shares in Issue: 5,195,355,938 shares (excluding Treasury shares).
Material Changes
The primary material change is the reduction of the Company's share capital through the cancellation of 644,360 shares purchased on December 5, 2008. Consequently, the total number of shares in issue was updated to 5,195,355,938.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It is a procedural announcement confirming compliance with the Financial Services Authority's Disclosure and Transparency Rules regarding the share buyback.
Investor Verification Points
- Verify the updated share count of 5,195,355,938 for calculating ownership thresholds under Disclosure and Transparency Rules.
- Confirm the Treasury share holding of 474,194,158 shares (9.13% of voting rights).
- Note that the repurchased shares were cancelled rather than held for reissue.